1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst (LPA) Alberto Lopez made an unannounced visit to investigate the above-mentioned allegation. LPA met with Julie Ann Oviedo, DSP and discussed the purpose of the visit.
The investigation consisted of LPA taking tour of facility, interviewing two (2) staff S#1 – S#2 and attempted to interview four (4) residents but unable to due to cognitive impairments. LPA obtained staff and Client rosters, reviewed C1 medications, Corrective action plan (CAP) from Regional Center and Incident report.
The investigation revealed: Regarding Allegation: Staff did not dispense client's medication as required. It is alleged that on January 7, 2026, the PM dose of clonazepam was dispensed and given to C1. However, during the review by Regional Center staff on January 8, 2026, it was discovered that the medication remained in the bubble pack. (Continued on (9099C)
|